BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28147896)

  • 1. The effectiveness of Lee Silverman Voice Treatment therapy issued interactively through an iPad device: A non-inferiority study.
    Griffin M; Bentley J; Shanks J; Wood C
    J Telemed Telecare; 2018 Apr; 24(3):209-215. PubMed ID: 28147896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovative technology for the assisted delivery of intensive voice treatment (LSVT®LOUD) for Parkinson disease.
    Halpern AE; Ramig LO; Matos CE; Petska-Cable JA; Spielman JL; Pogoda JM; Gilley PM; Sapir S; Bennett JK; McFarland DH
    Am J Speech Lang Pathol; 2012 Nov; 21(4):354-67. PubMed ID: 23071195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on ataxic dysarthria: a case study.
    Sapir S; Spielman J; Ramig LO; Hinds SL; Countryman S; Fox C; Story B
    Am J Speech Lang Pathol; 2003 Nov; 12(4):387-99. PubMed ID: 14658991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lee Silverman Voice Treatment for dysarthria in patients with Parkinson's disease: a systematic review and meta-analysis.
    Yuan F; Guo X; Wei X; Xie F; Zheng J; Huang Y; Huang Z; Chang Z; Li H; Guo Y; Chen J; Guo J; Tang B; Deng B; Wang Q
    Eur J Neurol; 2020 Oct; 27(10):1957-1970. PubMed ID: 32539227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The progress in the rehabilitation of dysarthria in Parkinson disease using LSVT (Lee Silverman Voice Treatment)].
    Kamińska I; Zebryk-Stopa A; Pruszewicz A; Dziubalska-Kołaczyk K; Połczyńska-Fiszer M; Pietrala D; Przedpelska-Ober E
    Otolaryngol Pol; 2007; 61(5):713-8. PubMed ID: 18552005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multicentre, randomised controlled trial to compare the clinical and cost-effectiveness of Lee Silverman Voice Treatment versus standard NHS Speech and Language Therapy versus control in Parkinson's disease: a study protocol for a randomised controlled trial.
    Sackley CM; Rick C; Au P; Brady MC; Beaton G; Burton C; Caulfield M; Dickson S; Dowling F; Hughes M; Ives N; Jowett S; Masterson-Algar P; Nicoll A; Patel S; Smith CH; Woolley R; Clarke CE;
    Trials; 2020 May; 21(1):436. PubMed ID: 32460885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
    Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
    Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
    Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
    Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings.
    Sapir S; Spielman JL; Ramig LO; Story BH; Fox C
    J Speech Lang Hear Res; 2007 Aug; 50(4):899-912. PubMed ID: 17675595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Home-based speech treatment for Parkinson's disease delivered remotely: a case report.
    Constantinescu GA; Theodoros DG; Russell TG; Ward EC; Wilson SJ; Wootton R
    J Telemed Telecare; 2010; 16(2):100-4. PubMed ID: 20008051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes to articulation following LSVT(R) and traditional dysarthria therapy in non-progressive dysarthria.
    Wenke RJ; Cornwell P; Theodoros DG
    Int J Speech Lang Pathol; 2010 Jun; 12(3):203-20. PubMed ID: 20433339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of Lee Silverman Voice Treatment (LSVT) on hypernasality in non-progressive dysarthria: the need for further research.
    Wenke RJ; Theodoros D; Cornwell P
    Int J Lang Commun Disord; 2010; 45(1):31-46. PubMed ID: 19565392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study.
    Howell S; Tripoliti E; Pring T
    Int J Lang Commun Disord; 2009; 44(3):287-300. PubMed ID: 18821113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Lee Silverman Voice Treatment (LSVT LOUD®) on swallowing and cough in Parkinson's disease: A pilot study.
    Miles A; Jardine M; Johnston F; de Lisle M; Friary P; Allen J
    J Neurol Sci; 2017 Dec; 383():180-187. PubMed ID: 29246611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Voice Treatment (Lee Silverman Voice Treatment [LSVT LOUD]) for Children With Down Syndrome: Phase I Outcomes.
    Boliek CA; Halpern A; Hernandez K; Fox CM; Ramig L
    J Speech Lang Hear Res; 2022 Apr; 65(4):1228-1262. PubMed ID: 35230877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive voice treatment (LSVT) for patients with Parkinson's disease: a 2 year follow up.
    Ramig LO; Sapir S; Countryman S; Pawlas AA; O'Brien C; Hoehn M; Thompson LL
    J Neurol Neurosurg Psychiatry; 2001 Oct; 71(4):493-8. PubMed ID: 11561033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.